{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuroinflammatory+Diseases", "query": { "condition": "Neuroinflammatory Diseases" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 387, "total_pages": 39, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuroinflammatory+Diseases&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-11T04:05:13.536Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04721717", "title": "AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinal Cord Injuries", "Multiple Sclerosis", "Transverse Myelitis", "Amyotrophic Lateral Sclerosis" ], "interventions": [], "intervention_types": [], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2020-09-01", "completion_date": "2027-03-28", "has_results": false, "last_update_posted_date": "2025-08-08", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04721717" }, { "nct_id": "NCT00582088", "title": "Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Venezuelan Equine Encephalomyelitis" ], "interventions": [ { "name": "VEE C-84", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "U.S. Army Medical Research and Development Command", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 500, "start_date": "2008-03", "completion_date": "2021-12", "has_results": false, "last_update_posted_date": "2021-02-11", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Fort Deterick, Maryland", "locations": [ { "city": "Fort Deterick", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00582088" }, { "nct_id": "NCT00459316", "title": "Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "HIV Infections", "Meningitis" ], "interventions": [ { "name": "Quadrivalent meningococcal conjugate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "24 Years", "sex": "ALL", "summary": "2 Years to 24 Years" }, "enrollment_count": 384, "start_date": "2007-06", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2021-11-03", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 35, "location_summary": "Alhambra, California • Long Beach, California • Los Angeles, California + 25 more", "locations": [ { "city": "Alhambra", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00459316" }, { "nct_id": "NCT04480333", "title": "Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Covid19", "Corona Virus Infection", "Severe Acute Respiratory Syndrome", "Severe Acute Respiratory Infection", "Severe Acute Respiratory Syndrome (SARS) Pneumonia", "Severe Acute Respiratory Syndrome of Upper Respiratory Tract", "Neurodegeneration", "Neuroinflammatory Response" ], "interventions": [ { "name": "Drug: NA-831 - 0.10 mg/kg", "type": "DRUG" }, { "name": "Placebo- 0.10 mg/kg", "type": "DRUG" }, { "name": "Drug: NA-831 - 0.20 mg/kg", "type": "DRUG" }, { "name": "Placebo- 0.20 mg/kg", "type": "DRUG" }, { "name": "Drug: GS-5734 - 1.00 mg/kg", "type": "DRUG" }, { "name": "Placebo- 1.00 mg/kg", "type": "DRUG" }, { "name": "Drug: GS-5734 - 2.00 mg/kg", "type": "DRUG" }, { "name": "Placebo- 2.00 mg/kg", "type": "DRUG" }, { "name": "Drugs: NA-831 (0.10 mg/kg) plus GS-5734 (1.00 mg/kg)", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo 0.10 mg + 1.00 mg/kg", "type": "COMBINATION_PRODUCT" }, { "name": "Drugs: NA-831 (0.20 mg/kg) plus GS-5734 (2.00 mg/kg)", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo 0.20 mg + 2.00 mg/kg", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Biomed Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "21 Years to 50 Years" }, "enrollment_count": 45, "start_date": "2020-09-15", "completion_date": "2021-03-31", "has_results": false, "last_update_posted_date": "2020-07-21", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Sunnyvale, California", "locations": [ { "city": "Sunnyvale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04480333" }, { "nct_id": "NCT00381433", "title": "Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Encephalitis" ], "interventions": [ { "name": "AVI-4065 Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sarepta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "MALE", "summary": "18 Years to 64 Years · Male only" }, "enrollment_count": 12, "start_date": "2006-09", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2009-07-08", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00381433" }, { "nct_id": "NCT01132053", "title": "Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Progressive Multifocal Leukoencephalopathy" ], "interventions": [], "intervention_types": [], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2004-06", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01132053" }, { "nct_id": "NCT05273372", "title": "RESTORE ME -- RCT of Oxaloacetate on Improving Fatigue in ME/CFS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Myalgic Encephalomyelitis", "Chronic Fatigue Syndrome", "Fatigue" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Medical Food - Anhydrous Enol-Oxaloacetate", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Terra Biological LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 82, "start_date": "2022-03-15", "completion_date": "2024-11-15", "has_results": false, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05273372" }, { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT00029523", "title": "DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Meningeal Neoplasms" ], "interventions": [ { "name": "Intrathecal (injected into the spinal fluid) DepoCyt", "type": "DRUG" }, { "name": "Intrathecal methotrexate", "type": "DRUG" }, { "name": "Intrathecal cytarabine (also known as ara-C)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pacira Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2001-04", "completion_date": "2004-11", "has_results": false, "last_update_posted_date": "2007-02-28", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Berkeley, California • Los Angeles, California + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Berkeley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00029523" }, { "nct_id": "NCT01606150", "title": "Lumbar Punctures in Neonates: Improving Success Rates and Minimizing Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meningitis" ], "interventions": [ { "name": "1% lidocaine", "type": "DRUG" }, { "name": "topical lidocaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "8 Days", "sex": "ALL", "summary": "Up to 8 Days" }, "enrollment_count": 5, "start_date": "2012-11", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2016-12-13", "last_synced_at": "2026-06-11T04:05:13.536Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01606150" } ] }